Extraction of the atrial activity from the ECG based on independent component analysis with prior knowledge of the source kurtosis signs

In this work it will be shown that a contrast for independent component analysis based on prior knowledge of the source kurtosis signs (ica-sks) is able to extract atrial activity from the electrocardiogram when a constrained updating is introduced. A spectral concentration measure is used, only allowing signal pair updates when spectral concentration augments. This strategy proves to be valid for independent source extraction with priors on the spectral concentration. Moreover, the method is computationally attractive with a very low complexity compared to the recently proposed methods based on spatiotemporal extraction of the atrial fibrillation signal

Removing Ocular Movement Artefacts by a Joint Smoothened Subspace Estimator

To cope with the severe masking of background cerebral activity in the electroencephalogram (EEG) by ocular movement artefacts, we present a method which combines lower-order, short-term and higher-order, long-term statistics. The joint smoothened subspace estimator (JSSE) calculates the joint information in both statistical models, subject to the constraint that the resulting estimated source should be sufficiently smooth in the time domain (i.e., has a large autocorrelation or self predictive power). It is shown that the JSSE is able to estimate a component from simulated data that is superior with respect to methodological artefact suppression to those of FastICA, SOBI, pSVD, or JADE/COM1 algorithms used for blind source separation (BSS). Interference and distortion suppression are of comparable order when compared with the above-mentioned methods. Results on patient data demonstrate that the method is able to suppress blinking and saccade artefacts in a fully automated way

NEMA NU 2-2007 performance characteristics of GE Signa integrated PET/MR for different PET isotopes

BackgroundFully integrated PET/MR systems are being used frequently in clinical research and routine. National Electrical Manufacturers Association (NEMA) characterization of these systems is generally done with F-18 which is clinically the most relevant PET isotope. However, other PET isotopes, such as Ga-68 and Y-90, are gaining clinical importance as they are of specific interest for oncological applications and for follow-up of Y-90-based radionuclide therapy. These isotopes have a complex decay scheme with a variety of prompt gammas in coincidence. Ga-68 and Y-90 have higher positron energy and, because of the larger positron range, there may be interference with the magnetic field of the MR compared to F-18. Therefore, it is relevant to determine the performance of PET/MR for these clinically relevant and commercially available isotopes.MethodsNEMA NU 2-2007 performance measurements were performed for characterizing the spatial resolution, sensitivity, image quality, and the accuracy of attenuation and scatter corrections for F-18, Ga-68, and Y-90. Scatter fraction and noise equivalent count rate (NECR) tests were performed using F-18 and Ga-68. All phantom data were acquired on the GE Signa integrated PET/MR system, installed in UZ Leuven, Belgium.Results(18)F, Ga-68, and Y-90 NEMA performance tests resulted in substantially different system characteristics. In comparison with F-18, the spatial resolution is about 1mm larger in the axial direction for Ga-68 and no significative effect was found for Y-90. The impact of this lower resolution is also visible in the recovery coefficients of the smallest spheres of Ga-68 in image quality measurements, where clearly lower values are obtained. For Y-90, the low number of counts leads to a large variability in the image quality measurements. The primary factor for the sensitivity change is the scale factor related to the positron emission fraction. There is also an impact on the peak NECR, which is lower for Ga-68 than for F-18 and appears at higher activities.ConclusionsThe system performance of GE Signa integrated PET/MR was substantially different, in terms of NEMA spatial resolution, image quality, and NECR for Ga-68 and Y-90 compared to F-18. But these differences are compensated by the PET/MR scanner technologies and reconstructions methods

Quantitative pretreatment VOI analysis of liver metastases 99mTc-MAA SPECT/CT and FDG PET/CT in relation with treatment response to SIRT

Using quantitive VOI analysis, the percentage Tc-99m-MAA uptake and SUVmax and mean values of liver metastases obtained prior to SIRT were related to treatment response using both a lesion-based and clinical dichotomous approach. Based on the VOI % of Tc-99m-MAA activity, the estimated Y-90-microspheres activity/cc (MBq/cc) was calculated from the effective dose injected. Baseline VOI FDG PET SUVmean and max values and estimated MBq/cc values were related to treatment response using a lesion-based approach (% change in SUVmean >= 50%) and a clinical dichotomous approach. Fifteen treatment sessions were analyzed (13 patients). Using the lesion-based approach (12 treatment sessions) 40 lesions responded and 37 did not. SUVmax and mean values proved significantly different between non-responding and responding lesions; 18:6 (SD 10.8) versus 13.5 (SD 8.4) for SUVmax (p = 0.02) and 11.4 (SD 3.8) versus 6.3 (SD 4.5) for SUVmean (p = 0.002). Using the clinical dichotomous approach (15 treatment sessions / 11 responding), 91 lesions were analyzed; 57 responded. VOI volumes and estimated Y-90-loaded glass microspheres activity (MBq/cc) did not differ between responders and non responders; 24 cc (SD 27) versus 21 cc (SD 21 cc) (p = 0.4) and 1.95 MBq/cc (SD 1.1 MBq/cc) versus 1.90 MB/cc (SD 2.7 MBq/cc) (p = 0.92). On the contrary, SUVmax and mean values proved significantly different between responders and non-responders; 23.7 (SD 9.8) versus 9.4 (SD 3.8) for SUVmax (p = 0.0001) and 13.1 (SD 8.1) versus 4.9 (SD 1.4) for SUVmean. Conclusion: These findings suggest that in patients presenting with high baseline SUVmax and mean values, the administration of higher activities or alternatively, other potentially more useful treatment options might be considered